{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:45:54Z","timestamp":1780472754460,"version":"3.54.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.rdc.2023.06.002","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T08:05:25Z","timestamp":1689753925000},"page":"741-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Type I Interferonopathies"],"prefix":"10.1016","volume":"49","author":[{"given":"Christine S.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.rdc.2023.06.002_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.rdc.2023.06.002_bib2","doi-asserted-by":"crossref","first-page":"631329","DOI":"10.3389\/fped.2021.631329","article-title":"Type I Interferonopathies in Children: An Overview","volume":"9","author":"d'Angelo","year":"2021","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.002_bib3","first-page":"750","article-title":"Molecular Genetics and Interferon Signature in the Italian Aicardi Goutieres Syndrome Cohort: Report of 12 New Cases and Literature Review","volume":"8","author":"Garau","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.002_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Goutieres syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.002_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/521373","article-title":"Clinical and molecular phenotype of Aicardi-Goutieres syndrome","volume":"81","author":"Rice","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2023.06.002_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/bmb\/ldn049","article-title":"Aicardi-Goutieres syndrome","volume":"89","author":"Orcesi","year":"2009","journal-title":"Br Med Bull"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.002_bib7","doi-asserted-by":"crossref","first-page":"E1836","DOI":"10.1002\/humu.21357","article-title":"Cerebral arterial stenoses and stroke: novel features of Aicardi-Goutieres syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression","volume":"31","author":"Thiele","year":"2010","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.002_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","volume":"167A","author":"Crow","year":"2015","journal-title":"Am J Med Genet"},{"issue":"12","key":"10.1016\/j.rdc.2023.06.002_bib9","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.3390\/ijms22126360","article-title":"Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives","volume":"22","author":"Di Donato","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.002_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2007-973555","article-title":"Aicardi-Goutieres syndrome: an expanding phenotype","volume":"29","author":"McEntagart","year":"1998","journal-title":"Neuropediatrics"},{"issue":"12","key":"10.1016\/j.rdc.2023.06.002_bib11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/dmcn.13509","article-title":"Late diagnosis and atypical brain imaging of Aicardi-Goutieres syndrome: are we failing to diagnose Aicardi-Goutieres syndrome-2?","volume":"59","author":"Svingen","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.002_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/jir.2011.0045","article-title":"Type I interferon and systemic lupus erythematosus","volume":"31","author":"Elkon","year":"2011","journal-title":"J\u00a0Interferon Cytokine Res"},{"issue":"9","key":"10.1016\/j.rdc.2023.06.002_bib13","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.06.002_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway","volume":"7","author":"Macedo","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.rdc.2023.06.002_bib15","doi-asserted-by":"crossref","first-page":"109299","DOI":"10.1016\/j.clim.2023.109299","article-title":"Altered DNA methylation and gene expression predict disease severity in patients with Aicardi-Goutieres syndrome","volume":"249","author":"Garau","year":"2023","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.002_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2015.03.007","article-title":"Clinical presentation of human C1q deficiency: How much of a lupus?","volume":"67","author":"Stegert","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.rdc.2023.06.002_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fimmu.2016.00036","article-title":"Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases","volume":"7","author":"Lintner","year":"2016","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.002_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/rheumatology\/kem023","article-title":"Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency","volume":"46","author":"Jonsson","year":"2007","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.002_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/rheumatology\/kev436","article-title":"Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus","volume":"55","author":"Pereira","year":"2016","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.002_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13075-015-0726-y","article-title":"A\u00a0subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources","volume":"17","author":"Leffler","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.rdc.2023.06.002_bib21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ng.975","article-title":"Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus","volume":"43","author":"Al-Mayouf","year":"2011","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.002_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/91070","article-title":"Mutation of DNASE1 in people with systemic lupus erythematosus","volume":"28","author":"Yasutomo","year":"2001","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.rdc.2023.06.002_bib23","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.38010","article-title":"DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome","volume":"65","author":"Ozcakar","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.002_bib24","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s10875-022-01287-5","article-title":"DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling","volume":"42","author":"Tusseau","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.002_bib25","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/s41467-017-01932-3","article-title":"Type I interferon-mediated autoinflammation due to DNase II deficiency","volume":"8","author":"Rodero","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.002_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajmg.a.33778","article-title":"Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus","volume":"155A","author":"Ravenscroft","year":"2011","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.002_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/jamadermatol.2014.3438","article-title":"Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1)","volume":"151","author":"Gunther","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.002_bib28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjd.20400","article-title":"Familial chilblain lupus in a child with heterozygous mutation in SAMHD1 and normal interferon signature","volume":"185","author":"Linggonegoro","year":"2021","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.002_bib29","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.39110","article-title":"Brief Report: IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency","volume":"67","author":"Van Eyck","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"7909","key":"10.1016\/j.rdc.2023.06.002_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.rdc.2023.06.002_bib31","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2012-12-469544","article-title":"Loss-of-function of the protein kinase C delta (PKCdelta) causes a B-cell lymphoproliferative syndrome in humans","volume":"121","author":"Kuehn","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.rdc.2023.06.002_bib32","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/art.38008","article-title":"Protein kinase cdelta deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation","volume":"65","author":"Belot","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2023.06.002_bib33","doi-asserted-by":"crossref","first-page":"e20210501","DOI":"10.1084\/jem.20210501","article-title":"Impaired respiratory burst contributes to infections in PKCdelta-deficient patients","volume":"218","author":"Neehus","year":"2021","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.002_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00277-022-04761-7","article-title":"ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies","volume":"101","author":"Consonni","year":"2022","journal-title":"Ann Hematol"},{"issue":"14","key":"10.1016\/j.rdc.2023.06.002_bib35","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMoa040036","article-title":"Autoimmune lymphoproliferative syndrome with somatic Fas mutations","volume":"351","author":"Holzelova","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.002_bib36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","article-title":"Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease","volume":"98","author":"Wu","year":"1996","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.002_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ajmg.a.31081","article-title":"Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: clinical and radiographic delineation of a pleiotropic disorder","volume":"140","author":"Renella","year":"2006","journal-title":"Am J Med Genet"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.002_bib38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/keh558","article-title":"Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus","volume":"44","author":"Wong","year":"2005","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.002_bib39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng.749","article-title":"Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity","volume":"43","author":"Lausch","year":"2011","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.002_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ng.748","article-title":"Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature","volume":"43","author":"Briggs","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.002_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.39810","article-title":"Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus","volume":"69","author":"An","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.002_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.002_bib43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/jir.2017.0127","article-title":"Development of a Validated Interferon Score Using NanoString Technology","volume":"38","author":"Kim","year":"2018","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.rdc.2023.06.002_bib44","doi-asserted-by":"crossref","first-page":"577918","DOI":"10.3389\/fped.2020.577918","article-title":"Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Systematic Review of Case Reports","volume":"8","author":"Dai","year":"2020","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.002_bib45","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","article-title":"Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients","volume":"9","author":"Fremond","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rdc.2023.06.002_bib46","doi-asserted-by":"crossref","first-page":"636225","DOI":"10.3389\/fimmu.2021.636225","article-title":"Case Report: Novel SAVI-Causing Variants in STING1 Expand the Clinical Disease Spectrum and Suggest a Refined Model of STING Activation","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.002_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaad.2015.10.007","article-title":"Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy","volume":"74","author":"Chia","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.rdc.2023.06.002_bib48","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamadermatol.2015.0251","article-title":"Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis","volume":"151","author":"Munoz","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.002_bib49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/cells11030318","article-title":"Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)","volume":"11","author":"David","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.002_bib50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/art.42087","article-title":"The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE\/PRAAS, SAVI, and AGS","volume":"74","author":"Cetin Gedik","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.002_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10875-019-00690-9","article-title":"STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib","volume":"40","author":"Tang","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.002_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10875-016-0271-8","article-title":"Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease","volume":"36","author":"Vece","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.002_bib53","doi-asserted-by":"crossref","first-page":"00017","DOI":"10.1183\/23120541.00017-2018","article-title":"Analysis of pulmonary features and treatment approaches in the COPA syndrome","volume":"4","author":"Tsui","year":"2018","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.002_bib54","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.33368","article-title":"Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"36","key":"10.1016\/j.rdc.2023.06.002_bib55","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1073\/pnas.1106015108","article-title":"Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome","volume":"108","author":"Arima","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.002_bib56","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ajhg.2010.10.031","article-title":"PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome","volume":"87","author":"Agarwal","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.002_bib57","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1172\/JCI81260","article-title":"Additive loss-of-function proteasome subunit mutations in CANDLE\/PRAAS patients promote type I IFN production","volume":"125","author":"Brehm","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.rdc.2023.06.002_bib58","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fimmu.2017.00927","article-title":"CANDLE Syndrome As a Paradigm of Proteasome-Related Autoinflammation","volume":"8","author":"Torrelo","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.002_bib59","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ajhg.2018.04.010","article-title":"Heterozygous Truncating Variants in POMP Escape Nonsense-Mediated Decay and Cause a Unique Immune Dysregulatory Syndrome","volume":"102","author":"Poli","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.002_bib60","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s10875-021-01067-7","article-title":"Curative Treatment of POMP-Related Autoinflammation and Immune Dysregulation (PRAID) by Hematopoietic Stem Cell Transplantation","volume":"41","author":"Meinhardt","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.002_bib61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajhg.2014.12.014","article-title":"A\u00a0specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome","volume":"96","author":"Rutsch","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.002_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10875-018-0572-1","article-title":"DDX58 and Classic Singleton-Merten Syndrome","volume":"39","author":"Ferreira","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.002_bib63","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajhg.2014.11.019","article-title":"Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome","volume":"96","author":"Jang","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.002_bib64","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ajmg.a.35732","article-title":"Singleton-Merten syndrome: an autosomal dominant disorder with variable expression","volume":"161A","author":"Feigenbaum","year":"2013","journal-title":"Am J Med Genet"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.002_bib65","doi-asserted-by":"crossref","first-page":"e931","DOI":"10.1002\/ctm2.931","article-title":"ISG15 deficiency features a complex cellular phenotype that responds to treatment with itaconate and derivatives","volume":"12","author":"Waqas","year":"2022","journal-title":"Clin Transl Med"},{"issue":"6102","key":"10.1016\/j.rdc.2023.06.002_bib66","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.1224026","article-title":"Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency","volume":"337","author":"Bogunovic","year":"2012","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.002_bib67","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41579-018-0020-5","article-title":"ISG15 in antiviral immunity and beyond","volume":"16","author":"Perng","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"7532","key":"10.1016\/j.rdc.2023.06.002_bib68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature13801","article-title":"Human intracellular ISG15 prevents interferon-alpha\/beta over-amplification and auto-inflammation","volume":"517","author":"Zhang","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.002_bib69","doi-asserted-by":"crossref","first-page":"107633","DOI":"10.1016\/j.celrep.2020.107633","article-title":"Systemic Type I IFN Inflammation in Human ISG15 Deficiency Leads to Necrotizing Skin Lesions","volume":"31","author":"Martin-Fernandez","year":"2020","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.002_bib70","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.20151529","article-title":"Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome","volume":"213","author":"Meuwissen","year":"2016","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.002_bib71","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1056\/NEJMoa1905633","article-title":"JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency","volume":"382","author":"Alsohime","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"42","key":"10.1016\/j.rdc.2023.06.002_bib72","doi-asserted-by":"crossref","first-page":"eaav7501","DOI":"10.1126\/sciimmunol.aav7501","article-title":"Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2","volume":"4","author":"Duncan","year":"2019","journal-title":"Sci Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.002_bib73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nsmb.3378","article-title":"STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling","volume":"24","author":"Arimoto","year":"2017","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.002_bib74","doi-asserted-by":"crossref","first-page":"e20192319","DOI":"10.1084\/jem.20192319","article-title":"Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy","volume":"217","author":"Gruber","year":"2020","journal-title":"J\u00a0Exp Med"},{"issue":"9","key":"10.1016\/j.rdc.2023.06.002_bib75","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.2948","article-title":"The SKIV2L RNA exosome limits activation of the RIG-I-like receptors","volume":"15","author":"Eckard","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2023.06.002_bib76","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3389\/fimmu.2018.01036","article-title":"Combined Immunodeficiency in Patients With Trichohepatoenteric Syndrome","volume":"9","author":"Vely","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.rdc.2023.06.002_bib77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-8-5","article-title":"Syndromic diarrhea\/Tricho-hepato-enteric syndrome","volume":"8","author":"Fabre","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.002_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/archdischild-2013-304016","article-title":"Syndromic (phenotypic) diarrhoea of infancy\/tricho-hepato-enteric syndrome","volume":"99","author":"Fabre","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.rdc.2023.06.002_bib79","doi-asserted-by":"crossref","first-page":"729763","DOI":"10.3389\/fimmu.2021.729763","article-title":"Mitochondrial Nucleic Acid as a Driver of Pathogenic Type I Interferon Induction in Mendelian Disease","volume":"12","author":"Lepelley","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.rdc.2023.06.002_bib80","doi-asserted-by":"crossref","first-page":"e20201560","DOI":"10.1084\/jem.20201560","article-title":"Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A","volume":"218","author":"Lepelley","year":"2021","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.002_bib81","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni.3409","article-title":"DNA polymerase-alpha regulates the activation of type I interferons through cytosolic RNA:DNA synthesis","volume":"17","author":"Starokadomskyy","year":"2016","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.002_bib82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10875-020-00953-w","article-title":"Immune Dysfunction in Mendelian Disorders of POLA1 Deficiency","volume":"41","author":"Starokadomskyy","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.002_bib83","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.002_bib84","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s11011-021-00716-5","article-title":"Ruxolitinib in Aicardi-Goutieres syndrome","volume":"36","author":"Mura","year":"2021","journal-title":"Metab Brain Dis"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.002_bib85","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3390\/ijms23052505","article-title":"Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside","volume":"23","author":"Sim","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.002_bib86","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/cells11071159","article-title":"STING Agonists\/Antagonists: Their Potential as Therapeutics and Future Developments","volume":"11","author":"Guerini","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.002_bib87","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/humu.23201","article-title":"A\u00a0SAMHD1 mutation associated with Aicardi-Goutieres syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans","volume":"38","author":"White","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.rdc.2023.06.002_bib88","doi-asserted-by":"crossref","first-page":"852903","DOI":"10.3389\/fped.2022.852903","article-title":"Case Report: Aicardi-Goutieres Syndrome Type 6 and Dyschromatosis Symmetrica Hereditaria With Congenital Heart Disease and Mitral Valve Calcification - Phenotypic Variants Caused by Adenosine Deaminase Acting on the RNA 1 Gene Homozygous Mutations","volume":"10","author":"Liu","year":"2022","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.002_bib89","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/jmedgenet-2019-106457","article-title":"Cardiac valve involvement in ADAR-related type I interferonopathy","volume":"57","author":"Crow","year":"2020","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.002_bib90","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5114\/fn.2016.64819","article-title":"Bilateral striatal necrosis caused by ADAR mutations in two siblings with dystonia and freckles-like skin changes that should be differentiated from Leigh syndrome","volume":"54","author":"Piekutowska-Abramczuk","year":"2016","journal-title":"Folia Neuropathol"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.002_bib91","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/humu.23975","article-title":"Genetic and phenotypic spectrum associated with IFIH1 gain-of-function","volume":"41","author":"Rice","year":"2020","journal-title":"Hum Mutat"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:32:45Z","timestamp":1760182365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X23000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0889857X23000625"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2023.06.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I Interferonopathies","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2023.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}